カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の哺乳類細胞発酵技術市場2023-2030：種類別、用途別（モノクローナル抗体、組換えタンパク質）、エンドユーザー別、地域別

【英語タイトル】Mammalian Cell Fermentation Technology Market Size, Share & Trends Analysis Report By Type, By Application (Monoclonal Antibodies, Recombinant Proteins), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23JUN002）・商品コード：GRV23JUN002
・発行会社（調査会社）：Grand View Research
・発行日：2023年5月19日
・ページ数：180
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：バイオ
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Grand View Research社の市場調査書によると、世界の哺乳類細胞発酵技術市場規模が、2030年までに762.4億ドルへ達すると見込まれています。本調査書では、哺乳類細胞発酵技術の世界市場を調査対象とし、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、種類別（チャイニーズハムスター卵巣（CHO）細胞発酵、ヒト胎児腎臓（HEK）細胞発酵、ベビーハムスター腎臓（BHK）細胞発酵、マウス骨髄腫細胞、その他）分析、用途別（モノクローナル抗体、組換えタンパク質、ワクチン、ホルモン剤、その他）分析、エンドユーザー別（バイオ医薬品企業、CMO・CDMO、学術・研究機関）分析、地域別（北米、ヨーロッパ、アジア太平洋中南米、中東・アフリカ）分析、競争状況などについて調査・分析し、まとめています。なお、こちらに掲載されている企業情報には、Thermo Fisher Scientific, Inc.、Merck KGaA、Danaher、Lonza、F. Hoffmann-La Roche Ltd、Sartorius AG、AstraZeneca、Bristol-Myers Squibb、Amgen、Gilead Sciences、Moderna, Inc、Regeneron Pharmaceuticalsなどが含まれています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界哺乳類細胞発酵技術の市場規模：種類別
- チャイニーズハムスター卵巣（CHO）細胞発酵の市場規模
- ヒト胎児腎臓（HEK）細胞発酵の市場規模
- ベビーハムスター腎臓（BHK）細胞発酵の市場規模
- マウス骨髄腫細胞の市場規模
- その他哺乳類細胞発酵技術の市場規模
・世界哺乳類細胞発酵技術の市場規模：用途別
- モノクローナル抗体における市場規模
- 組換えタンパク質における市場規模
- ワクチンにおける市場規模
- ホルモン剤における市場規模
- その他用途における市場規模
・世界哺乳類細胞発酵技術の市場規模：エンドユーザー別
- バイオ医薬品企業における市場規模
- CMO・CDMOにおける市場規模
- 学術・研究機関における市場規模
・世界哺乳類細胞発酵技術の市場規模：地域別
- 北米の哺乳類細胞発酵技術市場規模
- ヨーロッパの哺乳類細胞発酵技術市場規模
- アジア太平洋の哺乳類細胞発酵技術市場規模
- 中南米の哺乳類細胞発酵技術市場規模
- 中東・アフリカの哺乳類細胞発酵技術市場規模
・競争状況

哺乳類細胞発酵技術市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の哺乳類細胞発酵技術市場規模は2030年までに762億4000万米ドルに達すると予測されています。生物製剤の作成と製造における重要なステップは、哺乳類細胞発酵技術の利用です。いくつかの生物製剤はこの発酵技術で製造されており、癌、自己免疫疾患、感染症を含む様々な病気の治療に使用されています。哺乳動物細胞、主にチャイニーズハムスター卵巣（CHO）細胞は、タンパク質を作る技術に使用され、その後精製され、生物学的医薬品を作るために組み合わされます。これらの細胞は大規模なバイオリアクターで培養されます。生物製剤とバイオシミラーの必要性は、バイオ医薬品分野における技術の重要性を高めています。

哺乳類細胞発酵技術産業は、生物製剤やバイオシミラーの需要の増加、哺乳類細胞培養技術の進歩、慢性疾患の有病率の増加など様々な要因により、今後数年間で大きな成長が見込まれています。例えば、2021年1月、Merck KGaA社はドイツを拠点とするバイオテクノロジー企業のAmpTec社を買収しました。この買収によりMerck社は、生物製剤、バイオシミラー、哺乳類細胞の開発において重要性が急速に高まっているmRNA技術における能力を拡大することができます。さらに、この買収により、急成長しているmRNA受託開発・製造機関（CDMO）市場におけるMerck社の地位が強化されます。

COVID-19のパンデミックはまた、生物学の価値と効率的な医薬品の必要性を強調し、哺乳類細胞発酵技術産業の市場拡大を後押ししました。例えば、COVID-19ワクチンは、バイオテクノロジー企業Modernaが哺乳類細胞発酵技術を用いて作り出したもので、世界中の緊急事態での使用が承認されています。この例は、パンデミック時に哺乳類細胞発酵技術がいかに救命治療や治療法の開発に重要な役割を果たしたか、また今後の成長の可能性を浮き彫りにしています。

哺乳類細胞発酵技術市場レポートハイライト

– 種類別では、チャイニーズハムスター卵巣（CHO）細胞発酵分野が2022年に65.52%のシェアで市場を独占しました。その理由は、時間をかけて最適化され研究されてきた、よく理解された遺伝的・生化学的特性、高い生産性、手頃な価格、規制上の受容性などが挙げられます。

– 用途別では、モノクローナル抗体はCOVID-19を含む様々な疾患の治療に有効であるため、2022年のシェアは42.38%で、市場で圧倒的な存在感を示しています。

– 最終用途別では、CMO & CDMO分野が2022年に51.00%の最大市場シェアを占めました。これは、バイオ医薬品の生産を第三者メーカーに委託する傾向が強まっているためです。CDMOは効率的な生産に必要な専門知識、インフラ、設備を提供するため、バイオ医薬品企業の間で人気が高いです。

– 北米は2022年に37.61%のシェアを獲得し、同市場において確固たる地位を確立しました。高度に発達した医療インフラ、有利な政府政策、大手バイオ医薬品企業の存在感が強いためです。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Increasing Demand for Biologics
3.4.2. Increasing Investment in Research and Development of Novel Recombinant Proteins
3.4.3. Increasing Focus on Personalized Medicine and Precision Medicine
3.5. Market Restraint Analysis
3.5.1. High Cost Associated with The Production of Biologics Using Mammalian Cell Fermentation Technology
3.5.2. Regulatory Challenges
3.6. Penetration And Growth Prospect Mapping 2022
3.7. Business Environment Analysis
3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
3.7.2. Porter’s Five Forces Analysis
3.8. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. Mammalian Cell Fermentation Technology Market: Type Movement Analysis
4.2. Chinese Hamster Ovary (CHO) Cell Fermentation
4.2.1. Chinese Hamster Ovary (CHO) Cell Fermentation Market, 2018 – 2030 (USD Billion)
4.3. Human Embryonic Kidney (HEK) Cell Fermentation
4.3.1. Human Embryonic Kidney (HEK) Cell Fermentation Market, 2018 – 2030 (USD Billion)
4.4. Baby Hamster Kidney (BHK) Cell Fermentation
4.4.1. Baby Hamster Kidney (BHK) Cell Fermentation Market, 2018 – 2030 (USD Billion)
4.5. Murine Myeloma Cell Fermentation
4.5.1. Murine Myeloma Cell Fermentation Market, 2018 – 2030 (USD Billion)
4.6. Others
4.6.1. Other Types Market, 2018 – 2030 (USD Billion)
Chapter 5. Application Business Analysis
5.1. Monoclonal Antibodies
5.1.1. Monoclonal Antibodies Market, 2018 – 2030 (USD Billion)
5.2. Recombinant Proteins
5.2.1. Recombinant Proteins Market, 2018 – 2030 (USD Billion)
5.3. Vaccines
5.3.1. Vaccines Market, 2018 – 2030 (USD Billion)
5.4. Hormones
5.4.1. Hormones Market, 2018 – 2030 (USD Billion)
5.5. Enzymes
5.5.1. Enzymes Market, 2018 – 2030 (USD Billion)
5.6. Others
5.6.1. Other Applications Market, 2018 – 2030 (USD Billion)
Chapter 6. End-Use Business Analysis
6.1. Mammalian Cell Fermentation Technology Market: End-Use Movement Analysis
6.2. Biopharmaceutical Companies
6.2.1. Biopharmaceutical Companies Market, 2018 – 2030 (USD Billion)
6.3. CMOs & CDMOs
6.3.1. CMOs & CDMOs, Market, 2018 – 2030 (USD Billion)
6.4. Academic And Research Institutes
6.4.1. Academic And Research Institutes Market, 2018 – 2030 (USD Billion)
Chapter 7. Regional Business Analysis
7.1. Mammalian Cell Fermentation Technology Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. U.S. Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Target Disease Prevalence
7.2.4.3. Competitive Scenario
7.2.4.4. Regulatory Framework
7.2.4.5. Canada Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. UK Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.3.4. Germany
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Germany Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. France Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Italy Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Spain Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Denmark Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Sweden Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Target Disease Prevalence
7.3.10.3. Competitive Scenario
7.3.10.4. Regulatory Framework
7.3.10.5. Norway Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Japan Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. China Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. India Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Australia Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Thailand Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.4.8. South Korea
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.8.5. South Korea Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Brazil Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Mexico Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.5.5. Argentina Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. South Africa Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. Saudi Arabia Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.6.5. UAE
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. UAE Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Competitive Scenario
7.6.6.4. Regulatory Framework
7.6.6.5. Kuwait Mammalian Cell Fermentation Technology Market, 2018 – 2030 (USD Billion)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Merck KGaA
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Danaher
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Lonza
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. F. Hoffmann-La Roche Ltd
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Sartorius AG
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. AstraZeneca
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Bristol-Myers Squibb
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Amgen
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Gilead Sciences
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.11. Moderna, Inc
8.4.11.1. Overview
8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives
8.4.12. Regeneron Pharmaceuticals
8.4.12.1. Overview
8.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.12.3. Product Benchmarking
8.4.12.4. Strategic Initiatives

List of Tables

Table 1 List of abbreviations
Table 2 Global mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 3 Global mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 4 Global mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 5 Global mammalian cell fermentation technology market, by region, 2018 - 2030 (USD Billion)
Table 6 North America mammalian cell fermentation technology market, by country, 2018 - 2030 (USD Billion)
Table 7 North America mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 8 North America mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 9 North America mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 10 U.S. mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 11 U.S. mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 12 U.S. mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 13 Canada mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 14 Canada mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 15 Canada mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 16 Europe mammalian cell fermentation technology market, by country, 2018 - 2030 (USD Billion)
Table 17 Europe mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 18 Europe mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 19 Europe mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 20 UK mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 21 UK mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 22 UK mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 23 Germany mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 24 Germany mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 25 Germany mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 26 France mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 27 France mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 28 France mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 29 Italy mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 30 Italy mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 31 Italy mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 32 Spain mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 33 Spain mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 34 Spain mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 35 Denmark mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 36 Denmark mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 37 Denmark mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 38 Sweden mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 39 Sweden mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 40 Sweden mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 41 Norway mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 42 Norway mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 43 Norway mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 44 Asia Pacific mammalian cell fermentation technology market, by country, 2018 - 2030 (USD Billion)
Table 45 Asia Pacific mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 46 Asia Pacific mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 47 Asia Pacific mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 48 Japan mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 49 Japan mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 50 Japan mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 51 China mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 52 China mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 53 China mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 54 India mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 55 India mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 56 India mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 57 Australia mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 58 Australia mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 59 Australia mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 60 Thailand mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 61 Thailand mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 62 Thailand mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 63 South Korea mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 64 South Korea mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 65 South Korea mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 66 Latin America mammalian cell fermentation technology market, by country, 2018 - 2030 (USD Billion)
Table 67 Latin America mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 68 Latin America mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 69 Latin America mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 70 Brazil mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 71 Brazil mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 72 Brazil mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 73 Mexico mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 74 Mexico mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 75 Mexico mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 76 Argentina mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 77 Argentina mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 78 Argentina mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 79 Middle East & Africa mammalian cell fermentation technology market, by country, 2018 - 2030 (USD Billion)
Table 80 Middle East & Africa mammalian cell fermentation technology market, by type, 2018 - 2030 (USD
Table 81 Middle East & Africa mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 82 Middle East & Africa mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 83 South Africa mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 84 South Africa mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 85 South Africa mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 86 Saudi Arabia mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 87 Saudi Arabia mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 88 Saudi Arabia mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 89 UAE mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 90 UAE mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 91 UAE mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
Table 92 Kuwait mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
Table 93 Kuwait mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
Table 94 Kuwait mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)

★調査レポート[世界の哺乳類細胞発酵技術市場2023-2030：種類別、用途別（モノクローナル抗体、組換えタンパク質）、エンドユーザー別、地域別] (コード：GRV23JUN002)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の哺乳類細胞発酵技術市場2023-2030：種類別、用途別（モノクローナル抗体、組換えタンパク質）、エンドユーザー別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の生物製剤市場2023-2030：由来別（微生物、哺乳類）、製品別（MAB、組換えタンパク質、アンチセンス・RNAi）、疾患カテゴリー別、製造別、地域別
  • 世界のがん免疫治療薬市場2023-2030：製品別（モノクローナル抗体、免疫調節剤）、用途別、流通チャネル別、エンドユーザー別、地域別
  • 世界の神経免疫治療薬市場（～2030年）：製品タイプ別（モノクローナル抗体、低分子、組換えタンパク質、サイトカイン、リンパ球、その他）、疾患別、地域別
  • バイオ医薬品のグローバル市場（2023～2028）：モノクローナル抗体、組換え増殖因子、精製タンパク質、組換えタンパク質、その他
  • 世界の血友病市場2023-2030：種類別（血友病A）、治療種類別（オンデマンド）、治療法別（遺伝子治療、モノクローナル抗体）、流通チャネル別、地域別
  • 生物製剤の世界市場2023-2029：モノクローナル抗体、ワクチン、組換えタンパク質、アンチセンス、RNAi
  • 世界のレッドバイオテクノロジー市場2023-2030：製品別（モノクローナル抗体、ポリクローナル抗体、ワクチン、細胞ベースの免疫療法製品、遺伝子療法製品、その他）、エンドユーザー別（学術研究機関、CMO・CRO、製薬・バイオテクノロジー企業、その他）、地域別
  • 世界の鎌状赤血球症治療市場2024-2030：治療別（輸血、骨髄移植）、エンドユーザー別（病院、専門クリニック）、地域別
  • 世界の細胞透過性ペプチド市場2024-2030：種類別（タンパク質由来CPP、合成CPP、キメラCPP）、用途別（ドラッグデリバリー、遺伝子デリバリー）、エンドユーザー別（病院・クリニック、CRO）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆